Effects of TPN-12 Sandoz in schizophrenia
Pogorzelski, W.; Rogiewicz, A.; Wojdyslawska, I.
Psychiatria Polska 7(1): 65-68
1973
ISSN/ISBN: 0033-2674 PMID: 4715834 Document Number: 59998
Document emailed within 1 workday
Related Documents
Mádle, A.; Vainer, J.; Cepelák, V.; Brunát, J.; Smíd, J. 1991: Electrophysiological effects of oral isradipine (Lomir, Sandoz) Cor et Vasa 33(1): 35-41Obel, E.B. 1974: Demoxytocinum NFN (Sandopart, Sandoz) Ugeskrift for Laeger 136(49): 2762-2763
Wagner, M. 1990: 22 states file suit against Sandoz Modern Healthcare 20(51): 10
Gilden, D. 1995: Sandoz axes cyclosporine research Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 9(12): 7
1992: Clozapine suit settled against Sandoz and Caremark American Journal of Hospital Pharmacy 49(11): 2651
Shader, R.I.; Harmatz, J.S.; Salzman, C. 1988: Sandoz Clinical Assessment-Geriatric (SCAG) Psychopharmacology Bulletin 24(4): 765-769
Bogdaszewska-Czabanowska; Starzycki, Z. 1971: Studies on the use of BP400 Sandoz in allergic dermatoses Przeglad Dermatologiczny 58(1): 37-42
Tokarski, C. 1990: Sandoz pressured to make drug accessible Modern Healthcare 20(37): 39
Beveridge, T.; Niederer, W.; Nüesch, E.; Petrin, A. 1976: Pharmacokinetic study with synthetic salmon calcitonin (Sandoz) Zeitschrift für Gastroenterologie. Verhandlungsband 10: 12-15
Moroharu, T.; Watanabe, N.; Ito, M. 1983: Antipsychotic effects of caerulein on chronic schizophrenia Seishin Shinkeigaku Zasshi 85(9): 611-615
Zeher, M.; Antal, L.; Azad, A.Q.; Szegedi, G. 1988: Examination of the antihypertensive action of long-term estulic (Egis-Sandoz) treatment Therapia Hungarica 36(3): 103-108
Small, J.G.; Kellams, J.J.; Milstein, V.; Klapper, M.; Lemberger, L. 1977: Effects of lergotrile on schizophrenia and drug induced parkinsonism Communications in Psychopharmacology 1(5): 461-467
Sůla, K.; Svobodová, M.; Sobotková, E.; Nouza, K. 1991: Comparison of the immunomodulating properties of the cyclosporin Sandimmune (Sandoz) with the newly developed Consupren (Galena) Casopis Lekaru Ceskych 130(22-23): 656-660
Chanpattana, W.; Chakrabhand, M.L.; Kitaroonchai, W.; Choovanichvong, S.; Prasertsuk, Y. 1999: Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia Journal of the Medical Association of Thailand 82(5): 477-483
Morere, D.A.; Alarcon, R.D.; Monti, J.A.; Walter-Ryan, W.G.; Bancroft, A.J.; Smythies, J.R.; Tolbert, L.C. 1986: Medication effects on one-carbon metabolism in schizophrenia, mania, and major depression Journal of Clinical Psychopharmacology 6(3): 155-161
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335
Zaytseva, Y.; Burova, V.; Garakh, Z.; Gurovich, I.Y. 2013: Attributional style in fist episode of schizophrenia and schizophrenia spectrum disorders with and without paranoid ideation Psychiatria Danubina 25(Suppl 2): S329-S331
Roxo, H. 1952: Pseudoneurotics; patients at the onset of schizophrenia; differential diagnosis of neurasthenia and schizophrenia; modern therapy Imprensa Medica 28(463): 25-30
Kotlicka-Antczak, M.; Rabe-Jabłońska, J. 1997: Neurodevelopmental schizophrenia: the concept of developmental origins of certain forms of schizophrenia Psychiatria Polska 31(5): 527-538
Tsirkin, S.Iu. 1987: International study of schizophrenia based on a WHO program. Incidence of schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(8): 1203-1207